FDA Brief

Warning letters Drugs

FDA warning letter to

C & A Naturistics

High riskIssued Mar 4, 2025Posted Mar 11, 2025Center for Drug Evaluation and Research (CDER)

C & A Naturistics sold unapproved new drugs online, including AK Forte with hidden acetaminophen and diclofenac.

What happened

FDA reviewed the company’s website from May 2024 to February 2025 and found products marketed with claims to treat cancer, arthritis, kidney stones, infections, and other diseases. FDA also obtained and lab-tested a sample of AK Forte and found undeclared acetaminophen and diclofenac; the website also offered eye products for conjunctivitis and eyelid infections.

What FDA found

  1. The products are unapproved new drugs because they are intended to treat diseases but have no FDA-approved drug applications.

    sections 505(a) and 301(d) of the FD&C Act, 21 U.S.C. 355(a) and 331(d)
  2. AK Forte is misbranded because its labeling does not disclose that it contains acetaminophen and diclofenac.

    section 502(a) of the FD&C Act, 21 U.S.C. 352(a)
  3. TE DE MORONEL, Jengibre en Polvo, Té Uva Ursi, and RenaLimp are misbranded because they lack adequate directions for use by a layperson.

    section 502(f)(1) of the FD&C Act, 21 U.S.C. 352(f)(1); 21 CFR 201.5
  4. AK Forte is excluded from being a dietary supplement because it contains diclofenac, which was approved as a drug before being marketed as a supplement or food.

    section 201(ff)(3)(B)(i) of the FD&C Act, 21 U.S.C. 321(ff)(3)(B)(i)
  5. The website made drug claims for the products, such as treating cancer, arthritis, kidney stones, and conjunctivitis.

    section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)

What FDA wants

FDA asks the company to notify it in writing within 15 working days of the steps taken to correct the violations, with explanations and supporting documents, sent to FDAAdvisory@fda.hhs.gov with “CMS 693439” in the subject line.

Who should pay attention

  • retailers and online sellers of herbal or imported products
  • distributors and brands offering products with disease-treatment claims
  • consumers using imported herbal supplements or eye drops

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk